𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Amiloride is neuroprotective in an MPTP model of Parkinson's disease

✍ Scribed by Robert L. Arias; Mei-Li A. Sung; Dmytro Vasylyev; Mei-Yi Zhang; Kristin Albinson; Katie Kubek; Natasha Kagan; Chad Beyer; Qian Lin; Jason M. Dwyer; Margaret M. Zaleska; Mark R. Bowlby; John Dunlop; Michael Monaghan

Book ID
113812224
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
747 KB
Volume
31
Category
Article
ISSN
0969-9961

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Neuroprotective effects of (Β±)-kavain in
Neuroprotective effects of (Β±)-kavain in the MPTP mouse model of Parkinson's disease
✍ Nicole Schmidt; Boris Ferger πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 319 KB πŸ‘ 2 views

This is the first study to investigate the potential protective effects of the lipophilic kavapyrone (+/-)-kavain in the experimental MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) model of Parkinson's disease (PD). Male C57BL/6 mice were treated with (+/-)-kavain (50, 100, or 200 mg/kg i.p.) o

The MPTP model of Parkinson's disease
The MPTP model of Parkinson's disease
✍ Richard Jay Smeyne; Vernice Jackson-Lewis πŸ“‚ Article πŸ“… 2005 πŸ› Elsevier Science 🌐 English βš– 282 KB